Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate to Severe Gout”

4 trials

Showing 4 of 4 results

Testing effectiveness (Phase 2)Study completedNCT01109121
What this trial is testing

Tranilast Plus Allopurinol in Patients With Moderate to Severe Gout (TAnGO)

Who this might be right for
Moderate to Severe GoutHyperuricemia
Nuon Therapeutics, Inc. 112
Testing effectiveness (Phase 2)Study completedNCT02330796
What this trial is testing

Bucillamine for the Treatment of Acute Gout Flare in Subjects With Moderate to Severe Gout

Who this might be right for
Gout
Revive Therapeutics, Ltd. 66
Testing effectiveness (Phase 2)Study completedNCT01082640
What this trial is testing

Effect of Febuxostat on Renal Function in Patients With Gout and Moderate to Severe Renal Impairment

Who this might be right for
Renal Impairment
Takeda 96
Large-scale testing (Phase 3)Study completedNCT00549549
What this trial is testing

Celebrex In Acute Gouty Arthritis Study

Who this might be right for
Arthritis, Gouty
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 402

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation